Find Aceclidine Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 6109-70-2, Quinuclidin-3-yl acetate hydrochloride, Aceclidine (hydrochloride), Aceclidine hcl, 3-acetoxyquinuclidine hydrochloride, Aceclidine hydochloride
Molecular Formula
C9H16ClNO2
Molecular Weight
205.68  g/mol
InChI Key
LWWSARSTZGNKGV-UHFFFAOYSA-N
FDA UNII
3B22O325Q6

Aceclidine Hydrochloride
1 2D Structure

Aceclidine Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-azabicyclo[2.2.2]octan-3-yl acetate;hydrochloride
2.1.2 InChI
InChI=1S/C9H15NO2.ClH/c1-7(11)12-9-6-10-4-2-8(9)3-5-10;/h8-9H,2-6H2,1H3;1H
2.1.3 InChI Key
LWWSARSTZGNKGV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)OC1CN2CCC1CC2.Cl
2.2 Other Identifiers
2.2.1 UNII
3B22O325Q6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aceclidin

2. Aceclidine

3. Glaucadrine

4. Glaucocare

5. Glaucostat

6. Glaucotat

2.3.2 Depositor-Supplied Synonyms

1. 6109-70-2

2. Quinuclidin-3-yl Acetate Hydrochloride

3. Aceclidine (hydrochloride)

4. Aceclidine Hcl

5. 3-acetoxyquinuclidine Hydrochloride

6. Aceclidine Hydochloride

7. 1-azabicyclo[2.2.2]oct-3-yl Acetate Hydrochloride

8. 1-azabicyclo[2.2.2]octan-3-yl Acetate;hydrochloride

9. 3b22o325q6

10. (+/-)-3-acetoxyquinuclidine Hydrochloride; 3-acetoxyquinuclidine Hydrochloride

11. Einecs 228-071-5

12. C 162 D

13. Unii-3b22o325q6

14. 1-azabicyclo(2.2.2)octan-3-ol, Acetate (ester), Hydrochloride

15. Aceclidine, Hydrochloride

16. 3-quinclidinol Dl-form Acetate Hydrochloride

17. 3-quinuclidinol, Acetate (ester), Hydrochloride

18. Schembl6237805

19. Chembl4303558

20. Dtxsid30976587

21. Ccg-39134

22. Mfcd00136230

23. Ab03765

24. Ccg-220635

25. Aceclidine Hydrochloride [mart.]

26. Aceclidine Hydrochloride [who-dd]

27. Db-053792

28. Ft-0621714

29. Sw220059-1

30. A833043

31. Sr-01000597817

32. 3-quinuclidinol Dl-form Acetate Hydrochloride

33. Sr-01000597817-1

34. Q27256986

35. 3-quinuclidinol Dl-form Acetate Hydrochloride [mi]

36. 1-azabicyclo[2.2.2]octan-3-yl Acetate--hydrogen Chloride (1/1)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 205.68 g/mol
Molecular Formula C9H16ClNO2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass205.0869564 g/mol
Monoisotopic Mass205.0869564 g/mol
Topological Polar Surface Area29.5 Ų
Heavy Atom Count13
Formal Charge0
Complexity185
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Parasympathomimetics

Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)


Miotics

Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)


API SUPPLIERS

read-more
read-more

01

Neuland Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Neuland

02

Olon S.p.A

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

FNCE
Not Confirmed
arrow

Olon S.p.A

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
FNCE
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

03

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

FNCE
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
FNCE
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

04

J&H CHEM

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

FNCE
Not Confirmed
arrow

J&H CHEM

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
FNCE
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Conscientia Industrial

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

FNCE
Not Confirmed
arrow

06

Ningbo Inno Pharmchem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

FNCE
Not Confirmed
arrow

07

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

FNCE
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
FNCE
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

Olon SpA

Italy
FNCE
Not Confirmed
arrow

Olon SpA

Italy
arrow
FNCE
Not Confirmed

ACECLIDINE HYDROCHLORIDE

NDC Package Code : 17337-0058

Start Marketing Date : 2014-08-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

Olon USA LLC

Country
FNCE
Not Confirmed
arrow

Olon USA LLC

Country
arrow
FNCE
Not Confirmed

ACECLIDINE HYDROCHLORIDE

NDC Package Code : 71604-0002

Start Marketing Date : 2022-10-24

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

Curia Italy s.r.l.

Country
FNCE
Not Confirmed
arrow

Curia Italy s.r.l.

Country
arrow
FNCE
Not Confirmed

ACECLIDINE HYDROCHLORIDE

NDC Package Code : 55486-1608

Start Marketing Date : 2024-09-19

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

Aceclidine

About the Company : Established in 1984, Neuland Laboratories Limited is a publicly listed company headquartered in Hyderabad, India. The company provides solutions across the entire spectrum of the p...

Established in 1984, Neuland Laboratories Limited is a publicly listed company headquartered in Hyderabad, India. The company provides solutions across the entire spectrum of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. Neuland’s expertise is in the manufacturing of APIs and advanced intermediates from its USFDA-approved facilities. Its core competency lies in the application of powerful process chemistry to manufacturing in a regulatory-compliant environment.
Neuland

02

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

Aceclidine

About the Company : Conscientia Industrial is a pharmaceutical company, mainly developing, manufacturing, marketing APIs (Active Pharmaceutical Ingredients), intermediates, fine chemicals in China. We...

Conscientia Industrial is a pharmaceutical company, mainly developing, manufacturing, marketing APIs (Active Pharmaceutical Ingredients), intermediates, fine chemicals in China. We started business in early 2010, producing and providing products for both human and veterinary health at home and abroad. Conscientia Industrial makes regular productions and also provides custom synthesis, contract manufacturing services. We have series of products, such as Hormones, Prostaglandins, Peptides, Anti-cancer, Anti-tumor, Anti-virus, Anti-diabetic APIs and their related intermediates, impurities, chemicals.
blank

03

J&H CHEM

China
FNCE
Not Confirmed
arrow

J&H CHEM

China
arrow
FNCE
Not Confirmed

Aceclidine

About the Company : J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Valu...

J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Value-added customer services, for diversified range products of chemicals, pharmaceuticals, and specialities. As a highly customer-oriented enterprise, we always believe "Customer first, service foremost", put forward innovation, continuously improve pipeline, integrate our broad range of products and services with our technical expertise, customise a competitive package to meet our customers' specific needs.
blank

04

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

Aceclidine

About the Company : NINGBO INNO PHARMCHEM CO.,LTD. develop, pilot and commercial produce organic chemicals, pharmaceutical intermediates and nutraceuticals. We also offer custom synthesis and manufact...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Vizz (aceclidine) is a cholinergic agonist, small molecule drug, which is indicated for the treatment of presbyopia in adults.


Lead Product(s): Aceclidine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Vizz

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 31, 2025

blank

01

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : Vizz (aceclidine) is a cholinergic agonist, small molecule drug, which is indicated for the treatment of presbyopia in adults.

Product Name : Vizz

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 31, 2025

blank

Details:

Under the terms of the licensing agreement, Théa will commercialize LNZ100 (aceclidine HCl) for the treatment of presbyopia in Canada.


Lead Product(s): Aceclidine Hydrochloride,Brimonidine Tartrate

Therapeutic Area: Ophthalmology Brand Name: Vizz

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Laboratoires Thea

Deal Size: Undisclosed Upfront Cash: $70.0 million

Deal Type: Licensing Agreement July 07, 2025

blank

02

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : Under the terms of the licensing agreement, Théa will commercialize LNZ100 (aceclidine HCl) for the treatment of presbyopia in Canada.

Product Name : Vizz

Product Type : Miscellaneous

Upfront Cash : $70.0 million

July 07, 2025

blank

Details:

Under the licensing agreement, Lotus will holds the rights of LNZ100 (Aceclidine HCl) in Korea, which is being evaluated for the treatment of Presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Brimonidine Tartrate

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Lotus Pharmaceutical

Deal Size: $125.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement May 09, 2025

blank

03

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : Under the licensing agreement, Lotus will holds the rights of LNZ100 (Aceclidine HCl) in Korea, which is being evaluated for the treatment of Presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

May 09, 2025

blank

Details:

LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, being developed for the treatment of presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 27, 2024

blank

04

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, being developed for the treatment of presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 27, 2024

blank

Details:

LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, being developed for the treatment of presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 21, 2024

blank

05

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, being developed for the treatment of presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 21, 2024

blank

Details:

LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, being developed for the treatment of presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 12, 2024

blank

06

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine, being developed for the treatment of presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 12, 2024

blank

Details:

The net proceeds will be used to fund the clinical advancement of LNZ100 (aceclidine & brimonidine tartrate), which is being evaluated in the late-stage clinical trial for the treatment of Presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Brimonidine Tartrate

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Ridgeback Capital

Deal Size: $30.0 million Upfront Cash: Undisclosed

Deal Type: Private Placement July 15, 2024

blank

07

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : The net proceeds will be used to fund the clinical advancement of LNZ100 (aceclidine & brimonidine tartrate), which is being evaluated in the late-stage clinical trial for the treatment of Presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

July 15, 2024

blank

Details:

LNZ101 is a fixed dose opthalmic solution of aceclidine (mAChRs agonist) & brimonidine (ADRA2 agonist), which is being evaluated for the treatment of presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Brimonidine Tartrate

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 03, 2024

blank

08

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : LNZ101 is a fixed dose opthalmic solution of aceclidine (mAChRs agonist) & brimonidine (ADRA2 agonist), which is being evaluated for the treatment of presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 03, 2024

blank

Details:

The net proceeds will advance LENZ’s lead programs, LNZ100 and LNZ101, preservative-free, single-use, once-daily eye drops for treating presbyopia.


Lead Product(s): Aceclidine Hydrochloride,Brimonidine Tartrate

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Versant Ventures

Deal Size: $53.5 million Upfront Cash: Undisclosed

Deal Type: Private Placement March 21, 2024

blank

09

Graphite Bio

U.S.A
arrow
FNCE
Not Confirmed

Graphite Bio

U.S.A
arrow
FNCE
Not Confirmed

Details : The net proceeds will advance LENZ’s lead programs, LNZ100 and LNZ101, preservative-free, single-use, once-daily eye drops for treating presbyopia.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

March 21, 2024

blank

Details:

The collaboration will advance LENZ’s lead programs, LNZ100 and LNZ101, preservative-free eye drops containing aceclidine and aceclidine plus brimonidine for presbyopia treatment.


Lead Product(s): Aceclidine Hydrochloride,Brimonidine Tartrate

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Graphite Bio

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Merger March 21, 2024

blank

10

FNCE
Not Confirmed
FNCE
Not Confirmed

Details : The collaboration will advance LENZ’s lead programs, LNZ100 and LNZ101, preservative-free eye drops containing aceclidine and aceclidine plus brimonidine for presbyopia treatment.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

March 21, 2024

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 6109-70-2 / Aceclidine Hydrochloride API manufacturers, exporters & distributors?

Aceclidine Hydrochloride manufacturers, exporters & distributors 1

39

PharmaCompass offers a list of Aceclidine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aceclidine Hydrochloride manufacturer or Aceclidine Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aceclidine Hydrochloride manufacturer or Aceclidine Hydrochloride supplier.

PharmaCompass also assists you with knowing the Aceclidine Hydrochloride API Price utilized in the formulation of products. Aceclidine Hydrochloride API Price is not always fixed or binding as the Aceclidine Hydrochloride Price is obtained through a variety of data sources. The Aceclidine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Aceclidine Hydrochloride

Synonyms

6109-70-2, Quinuclidin-3-yl acetate hydrochloride, Aceclidine (hydrochloride), Aceclidine hcl, 3-acetoxyquinuclidine hydrochloride, Aceclidine hydochloride

Cas Number

6109-70-2

Unique Ingredient Identifier (UNII)

3B22O325Q6

Aceclidine HCl Manufacturers

A Aceclidine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aceclidine HCl, including repackagers and relabelers. The FDA regulates Aceclidine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aceclidine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Aceclidine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Aceclidine HCl Suppliers

A Aceclidine HCl supplier is an individual or a company that provides Aceclidine HCl active pharmaceutical ingredient (API) or Aceclidine HCl finished formulations upon request. The Aceclidine HCl suppliers may include Aceclidine HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Aceclidine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Aceclidine HCl USDMF

A Aceclidine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Aceclidine HCl active pharmaceutical ingredient (API) in detail. Different forms of Aceclidine HCl DMFs exist exist since differing nations have different regulations, such as Aceclidine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Aceclidine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Aceclidine HCl USDMF includes data on Aceclidine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aceclidine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Aceclidine HCl suppliers with USDMF on PharmaCompass.

Aceclidine HCl NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aceclidine HCl as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Aceclidine HCl API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Aceclidine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Aceclidine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aceclidine HCl NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Aceclidine HCl suppliers with NDC on PharmaCompass.

Aceclidine HCl GMP

Aceclidine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Aceclidine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aceclidine HCl GMP manufacturer or Aceclidine HCl GMP API supplier for your needs.

Aceclidine HCl CoA

A Aceclidine HCl CoA (Certificate of Analysis) is a formal document that attests to Aceclidine HCl's compliance with Aceclidine HCl specifications and serves as a tool for batch-level quality control.

Aceclidine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Aceclidine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Aceclidine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Aceclidine HCl EP), Aceclidine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aceclidine HCl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty